Skip to main content
Signal8

AXIM BIOTECHNOLOGIES, INC. (AXIM)

AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye health, AXIM is pioneering quick, quantitative tear tests to measure Matrix metalloproteinase-9, an inflammatory marker associated with dry eye disease. In its oncology pipeline, the firm is advancing SBI-183, an anti-metastatic compound engineered to inhibit tumor cell growth and block the spread of cancer, as well as SPX-1009, another anti-metastatic therapy aimed at determining the levels of quiescin sulfhydryl oxidase I. Established in 2010, the company was formerly known as Axim International Inc. before officially changing its name to AXIM Biotechnologies, Inc. in July 2014, and it is headquartered in San Diego, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc.

OTC:AXIMHealthcare
+3.23%$0.0032
Mkt Cap$966K
Float294.99M
O/S301.96M
Inst Own-
SI0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$1.04M
Total Assets$2.88M
Free Cash Flow-$686K
Debt & Equity
Total Debt$7.78M
Total Equity-$11.37M
Preferred Stock$50
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in AXIM's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$2.88M
Liabilities$14.24M
Accounts Receivable$0
Accounts Payable$1.74M
Inventory$0
PP&E (Net)$66K
Goodwill$0
Intangible Assets$2.81M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue$0$70K$40K$9K$60K$0$799K$196K$48K$47K$49K$0$22K$43K$10K
YoY Growth-78.3%345.3%-85.3%--308.7%311.2%1.1%-4.2%---50.0%333.3%-
Cost of Revenue$427K$440K$427K$426K$2.12M$16K$576K$9K$43K$154K$50K$0$0$0$0
Gross Profit-$427K-$369K$40K-$417K$60K-$16K$224K$187K$5K-$107K-$1K$0$22K$43K$10K
Gross Margin--524.1%100.0%-4701.4%100.0%-28.0%95.6%9.9%-227.5%-2.5%-100.0%100.0%100.0%
Research and Development$180K$40K$125K$154K$285K$427K$2.45M$2.06M$1.35M$236K$571K$0$0$0$0
Selling, General, and Administrative$712K$1.35M$2.24M$4.08M$5.67M$4.51M$4.27M$3.16M$1.8M$3.41M$9.48M$506K$33K$41K$0
Other$0$432K$427K$426K$1.84M-$100K$3K$3K$3K$3K$1K$0$111K$58K$13K
Total Operating Expenses$892K$1.39M$2.79M$4.66M$7.79M$4.83M$6.73M$5.22M$3.15M$3.65M$10.05M$506K$111K$58K$13K
Operating Income (EBIT)-$1.32M-$1.76M-$2.75M-$4.65M-$7.99M-$4.95M-$6.51M-$5.04M-$3.15M-$3.76M-$10.05M-$506K-$89K-$15K-$3K
Operating Margin--2502.3%-6961.0%-52425.6%-13207.1%--813.7%-2574.5%-6619.5%-7988.8%-20451.3%--411.8%-34.4%-27.9%
Interest Expense$342K$636K$1.2M$1.88M$743K$321K$324K$1.58M$1.02M$301K$43K$33K$0$0$0
Interest Income$0$0$0$257$1K$675$298K$0$2K$0$0$0$0$0$0
Other Income (Expense)$277K-$1.75M-$5.31M-$1.59M-$2.05M-$1.34M$58K-$1.72M-$1.02M-$2.05M-$43K-$33K$0$0$0
Income Before Tax (EBT)-$1.04M-$3.51M-$8.06M-$6.24M-$16.02M-$6.29M-$6.45M-$6.75M-$4.17M-$5.81M-$10.09M-$538K-$89K-$15K-$3K
Income Tax Expense$0$0$0$0$0$0$324K$0$0$0$0$0-$30K$0$0
Net Income-$1.04M-$3.51M-$8.06M-$5.96M-$16.52M-$6.73M-$6.77M-$6.75M-$4.17M-$5.81M-$10.09M-$583K-$89K-$15K-$3K
Net Income Margin--4985.2%-20395.0%-67120.7%-27320.8%--847.0%-3453.0%-8761.7%-12346.0%-20539.2%--411.8%-34.4%-27.9%
Supplementary Data
EPS-0.00-0.01-0.04-0.04-0.13-0.06-0.11-0.12-0.08-0.14-0.27-0.02-0.00-0.00-0.00
Diluted EPS-0.00-0.01-0.04-0.04-0.13-0.06-0.11-0.12-0.08-0.14-0.27-0.02-0.00-0.00-0.00
Weighted Average OS340.46M318.90M227.69M165.47M131.54M110.39M61.95M57.28M53.30M41.73M37.05M33.00M33.00M33.00M23.28M
EBITDA-$892K-$2.44M-$6.43M-$3.94M-$13.17M-$4.93M-$2.67M-$5.16M-$3.14M-$5.51M-$10.05M-$504K-$79K-$9K-$2K
EBITDA Margin--3468.6%-16265.7%-44398.9%-21775.3%--333.5%-2639.3%-6609.1%-11698.3%-20449.0%--365.6%-21.8%-19.6%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Assets
Current Assets
Cash and Cash Equivalents$5K$245$156K$47K$453K$457K$512K$1.81M$2.06M$713K$134K$661K$127$19K$23K
Short-Term Investments$0$0$0$0$0$0$241K$150K$0$0$0$0$0$0$0
Cash and Short-Term Investments$5K$245$156K$47K$453K$457K$753K$1.96M$2.06M$713K$134K$661K$127$19K$23K
Accounts Receivable$0$0$0$0$0$0$321K$5K$5K$505K$5K$5K$3K$20K$0
Inventory$0$0$0$0$0$0$488K$10K$9K$38K$201K$0-$3K$0$0
Other Current Assets$0$0$0$14K$20K$0$27K$0$0$76K$0$0$3K$0$0
Total Current Assets$5K$755$156K$104K$637K$713K$1.64M$2.02M$2.11M$1.37M$1.18M$738K$3K$39K$23K
Long-Term Assets
Property, Plant & Equipment Net$66K$237K$361K$114K$194K$235K$2K$6K$9K$12K$16K$0$0$0$0
Goodwill$0$0$0$0$0$2.46M$0$0$0$0$0$0$0$0$0
Intangible Assets$2.81M$3.2M$3.59M$3.99M$4.38M$7.8M$51K$54K$63K$63K$63K$0$54K$94K$49K
Long-Term Investments$0$0$0$46K$104K$103K$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0-$46K-$104K-$103K$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$9K$9K$5K$109K$108K$0$7K$7K$0$0$0$0-$94K$0
Total Long-Term Assets$2.87M$3.45M$3.97M$4.11M$4.69M$10.6M$53K$67K$80K$75K$79K$0$54K$94K$49K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$2.88M$3.45M$4.12M$4.21M$5.32M$11.31M$1.69M$2.09M$2.19M$1.45M$1.26M$738K$57K$133K$72K
Liabilities
Current Liabilities
Accounts Payable$1.74M$1.79M$2.78M$1.32M$816K$738K$750K$218K$442K$401K$324K$144K$53K$33K$6K
Short-Term Debt$0$0$0$0$1.61M$369K$42K$2.69M$7.26M$2.61M$1.11M$1.11M$50K$50K$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$233K$303K$333K$0$0$0$0$0$0$0$0$0$22K$0
Other Current Liabilities$4.34M$4.67M$2.8M$1.72M$180$180$2.6M$413K$0$5K$1.11M$94K$48K$33K$51K
Total Current Liabilities$6.08M$6.76M$5.98M$3.39M$2.58M$1.5M$3.4M$3.32M$7.71M$3.02M$2.56M$1.32M$151K$138K$56K
Long-Term Liabilities
Long-Term Debt$7.78M$6.5M$5.66M$5.64M$5.06M$5.84M$5.06M$4.85M$772K$804K$400K$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0-$2.34M$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$2.34M$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$381K$541K$0$0$0$2.34M$0$0$0$0$11K$0$0$0$6K
Total Long-Term Liabilities$8.17M$7.1M$5.8M$5.64M$5.08M$8.25M$5.06M$4.85M$772K$804K$400K$1.19M$103K$104K$6K
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0-$1.19M-$103K-$104K$0
Total Liabilities$14.24M$13.87M$11.78M$9.04M$7.66M$9.75M$8.45M$8.17M$8.48M$3.82M$2.96M$1.32M$151K$138K$62K
Stockholders' Equity
Preferred Stock$50$50$50$50$50$50$100$100$100$100$200$100$100$100$100
Common Stock$34K$32K$25K$19K$14K$13K$6K$6K$5K$5K$4K$3K$3K$3K$3K
Retained Earnings-$76.74M-$75.7M-$72.18M-$64.13M-$57.88M-$41.85M-$35.44M-$28.99M-$22.24M-$18.07M-$10.78M-$692K-$109K-$20K-$5K
Comprehensive Income & Other$0$0-$24K$89K$4.53M$202K$50K-$100-$100-$100-$200-$100-$100-$100-$100
Other Stockholders' Equity$65.34M$65.25M$64.5M$59.28M$55.53M$43.4M$28.67M$22.9M$15.95M$15.69M$9.09M$108K$12K$12K$12K
Total Equity-$11.37M-$10.42M-$7.66M-$4.83M-$2.34M$1.57M-$6.76M-$6.08M-$6.28M-$2.37M-$1.7M-$581K-$94K-$5K$10K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$2.88M$3.45M$4.12M$4.21M$5.32M$11.31M$1.69M$2.09M$2.19M$1.45M$1.26M$738K$57K$133K$72K
Supplementary Data
Total Debt$7.78M$6.64M$5.89M$5.66M$6.72M$6.31M$6.1M$5.87M$6.4M$1.77M$1.45M$1.05M$50K$50K$0
Net Debt$7.78M$6.64M$5.74M$5.62M$6.27M$5.85M$5.59M$4.06M$4.34M$1.06M$1.32M$389K$50K$31K-$23K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Operating Activities
Net Income-$1.04M-$3.51M-$8.06M-$6.24M-$16.03M-$6.41M-$6.45M-$6.75M-$4.17M-$5.81M-$10.09M-$583K-$89K-$15K-$3K
Depreciation & Amortization$427K$432K$427K$426K$2.12M$16K$3K$13K$3K$3K$1K$2K$10K$5K$832
Deferred Income Tax$0$0$0$0$7.55M-$78K-$382K$140K$0$1.61M$673K$0$0$0$0
Stock-Based Compensation$0$0$198K$1.11M$1.14M$2.31M$1.83M$911K$56K$1.45M$5.98M$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$0$0$0$2K-$1K-$675-$316K$0$174K$0$0-$4K$9K$45K$0
  Inventory$0$0$0$20K-$20K$675-$478K-$1K$30K$153K$46K$0$0$0$0
  Accounts Payable-$361K$638K$769K$659K$277.51B$532K$674K-$116K$41K$189K$249K$146K$20K$27K$6K
  Other Working Capital-$52K$145K$523K$358K-$277.51B-$46K-$111K-$101K-$7K-$52K-$181K-$22K-$12K$3K$500
Total Working Capital Change-$412K$783K$1.29M$1.04M-$28K$486K-$231K-$218K$237K$290K$114K$123K$8K$31K$6K
Other Non-Cash Items$342K$1.44M$5.11M$1.63M$2.77M$459K$203K$1.06M$790K$1.17M$1.79M$118K$38K$31K$0
Net Cash from Operating-$686K-$855K-$1.03M-$2.04M-$2.49M-$3.22M-$5.02M-$4.85M-$3.08M-$1.29M-$1.54M-$339K-$33K$21K$4K
Investing Activities
Capital Expenditures$0-$3K$0-$9K-$50K-$97K$0$0$0$0-$17K$0$0-$100K$0
Acquisitions$0$0$0$0$0$80K-$27K$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$376K$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0-$9K-$10K$27K-$27K$0$0$0-$17K$0$0-$100K$0
Net Cash from Investing$0-$3K$0-$9K-$50K$10K$348K$0$0$0-$17K$0$0-$100K$0
Financing Activities
Debt Repaid-$650K-$480K-$675K$8K-$1.01M$93K-$11K$184K-$3.94M-$1.23M----$50K-
Common Stock Issuance$8K$222K$491K$1.74M$1.64M$3.31M$3.46M$4.37M$115K$115K$20K$0$0$0$13K
Common Stock Repurchases$0$0$0$0$0$0$0$0$5.3M$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0-$1.48M$0$0$0$0$0$0
Other Financing Activities$0$0-$27K-$87K$1.64M-$65K-$79K$408K$1.98M$533K$1.01M-$5K$0$25K$0
Net Cash from Financing$658K$702K$1.14M$1.65M$2.53M$3.15M$3.38M$4.59M$4.43M$1.87M$1.03M$1M$14K$75K$19K
Forex Effect$33K$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$5K-$156K$109K-$406K-$4K-$54K-$1.29M-$252K$1.34M$579K-$527K$661K-$19K-$4K$23K
Supplementary Data
Operating Cash Flow-$686K-$855K-$1.03M-$2.04M-$2.49M-$3.22M-$5.02M-$4.85M-$3.08M-$1.29M-$1.54M-$339K-$33K$21K$4K
Capital Expenditure$0-$3K$0-$9K-$50K-$97K$0$0$0$0-$17K$0$0-$100K$0
Free Cash Flow-$686K-$858K-$1.03M-$2.05M-$2.54M-$3.31M-$5.02M-$4.85M-$3.08M-$1.29M-$1.56M-$339K-$33K-$79K$4K
Cash at Beginning$245$156K$47K$453K$457K$512K$1.81M$2.06M$713K$134K$661K$127$19K$23K$0
Cash at End$5K$245$156K$47K$453K$457K$512K$1.81M$2.06M$713K$134K$661K$127$19K$23K